In the BioHarmony Drug Report Database

"Preview" Icon

Levobunolol

Betagan (levobunolol) is a small molecule pharmaceutical. Levobunolol was first approved as Betagan on 1985-12-19. It is used to treat open-angle glaucoma in the USA. The pharmaceutical is active against beta-3 adrenergic receptor, beta-2 adrenergic receptor, and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor.

 

Trade Name

 

Betagan
 

Common Name

 

levobunolol
 

ChEMBL ID

 

CHEMBL1201237
 

Indication

 

open-angle glaucoma
 

Drug Class

 

Beta-blockers (propranolol type)

Image (chem structure or protein)

Levobunolol structure rendering